Mako Nagayoshi
Lecturer
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (12)
Year:
2026
Year:
2026
Background Although utility of composite trait‐specific polygenic risk score (multi‐trait PRS) has been examined among European ancestries, few studies investigated among East Asians and incorporated modifiable risk factors. We examined the associations of multi‐trait PRS for cardiometabolic factors with cardiovascular disease mortality by integrating nongenetic determinants. Methods A total of 14 086 Japanese participants (mean age, 55±9; 55.8% women) of the J‐MICC (Japan Multi‐Institutional Collaborative Cohort) study were analyzed in this study. We calculated 6 PRSs for cardiometabolic traits (systolic blood pressure, body mass index, triglycerides, low‐density lipoprotein cholesterol, estimated glomerular filtration rate, and hemoglobin A1c). Based on these PRSs, we developed multi‐trait PRS and considered as a primary exposure. Three nongenetic factors (smoking, alcohol drinking, and educational attainment) from the self‐reported questionnaire were also examined. Results During a median 12.1‐year follow‐up period, a total of 472 all‐cause and 79 cardiovascular disease mortality cases were documented. Compared with 0% to 90% of multi‐trait PRSs, an adjusted hazard ratio (HR) among the top 10% of multi‐trait PRSs was 1.32 (95% CI, 1.00–1.73) for all‐cause death and 2.63 (95% CI, 1.48–4.67) for cardiovascular disease death. Incorporation of educational attainment with multi‐trait PRSs showed null associations in those who went beyond high school (HR, 2.07 [95% CI, 0.44–9.66]) even in the top 10% of multi‐trait PRS. Conclusions Our analysis combining both genetic and nongenetic determinants highlighted that lifestyle factors and educational attainment can slightly reduce an individual's composite genetic risk for cardiovascular disease death.
Year:
2025
Background Staying active in daily life is believed to help maintain individuals' oral motor function and prevent oral frailty, a potential risk factor for general health. However, there is limited epidemiological evidence of this association. This study focused on vocalising frequency as an indicator of activeness in daily life. Methods We conducted a home‐visit survey targeting residents aged ≥ 65 years in a rural community in the Goto Islands, Japan. Among 563 participants, those with missing data for the main outcome or vocalising ( n = 84) were excluded. Tongue pressure was measured thrice; we used maximum tongue pressure as a marker of tongue motor function. Frequency of conversation, laughter and other vocalising opportunities (e.g., singing or Buddhist chanting) was measured. The multivariate‐adjusted regression models were used to calculate parameter estimates (B) for tongue pressure according to the frequency of vocalisation. Results Among the 479 participants, the proportion of individuals who answered ‘every day’ was 77% for conversation, 48% for laughter and 47% for other vocalising opportunities. Participants engaging every day in other vocalising opportunities recorded higher maximum tongue pressure ( B = 2.26; p = 0.03) than those who did not at all. Sex did not affect this association ( p interaction = 0.72). Conversation and laughter every day overlapped with the everyday category of other vocalising opportunities, but they were not associated with tongue pressure. Conclusion Engaging every day in vocalising opportunities other than conversation or laughter was independently associated with a higher maximum tongue pressure in older adults than those who vocalised less often.
Year:
2025
Year:
2025
Flowcharts of the selection of study participants. A, Study participants for analyses of examination-based metabolic phenotypes. B, Study participants for analyses of questionnaire-based metabolic phenotypes.
Year:
2025
The present study investigated the relationship between metabolic phenotypes and the risk of cancer in a Japanese population using the criteria of metabolic phenotypes based on an examination and those based on questionnaires. We used data from 25,357 subjects for examination-based analyses and those from 53,042 subjects for questionnaire-based analyses in the Japan Multi-institutional Collaborative Cohort study. Metabolic phenotypes were defined by classifying subjects according to their body mass index (BMI; obesity: BMI ≥25 kg/m2; normal weight: BMI <25 kg/m2) and the number of metabolic abnormalities. Metabolic abnormalities were defined according to metabolic syndrome components of the Joint Interim Statement criteria for examination-based analyses and self-reported histories of diabetes, dyslipidemia, and hypertension for questionnaire-based analyses. Cox proportional hazards regression analyses adjusted for potential confounders were performed for total and site-specific cancer incidence rates according to metabolic phenotypes. Metabolically unhealthy obesity (MUHO) was significantly associated with cancer incidence in both examination-based [HR (95% confidence interval), 1.17 (1.01–1.36)] and questionnaire-based analyses [HR (95% confidence interval), 1.15 (1.04–1.26)]. Regarding site-specific cancer in questionnaire-based analyses, metabolically healthy obesity and MUHO were associated with colorectum and liver cancers in all subjects and with breast cancer in female subjects. Subjects with a metabolically unhealthy normal weight had a higher risk of pancreatic cancer. Moreover, MUHO was associated with corpus uteri cancer in female subjects. This prospective cohort study suggests that metabolic phenotypes are important risk factors for total and some site-specific cancers in Japanese adults. Significance: The prospective cohort study in a large Japanese population suggested that metabolic phenotypes are important risk factors for total and some site-specific cancers in Japanese adults. Moreover, the risk of each site-specific cancer may differ according to metabolic phenotypes.
Year:
2024
Year:
2024
The present study investigated the relationship between metabolic phenotypes and the risk of cancer in a Japanese population using the criteria of metabolic phenotypes based on an examination and those based on questionnaires. We used data from 25,357 subjects for examination-based analyses and those from 53,042 subjects for questionnaire-based analyses in the Japan Multi-institutional Collaborative Cohort study. Metabolic phenotypes were defined by classifying subjects according to their body mass index (BMI; obesity: BMI ≥25 kg/m 2 ; normal weight: BMI 2 ) and the number of metabolic abnormalities. Metabolic abnormalities were defined according to metabolic syndrome components of the Joint Interim Statement criteria for examination-based analyses and self-reported histories of diabetes, dyslipidemia, and hypertension for questionnaire-based analyses. Cox proportional hazards regression analyses adjusted for potential confounders were performed for total and site-specific cancer incidence rates according to metabolic phenotypes. Metabolically unhealthy obesity (MUHO) was significantly associated with cancer incidence in both examination-based [HR (95% confidence interval), 1.17 (1.01–1.36)] and questionnaire-based analyses [HR (95% confidence interval), 1.15 (1.04–1.26)]. Regarding site-specific cancer in questionnaire-based analyses, metabolically healthy obesity and MUHO were associated with colorectum and liver cancers in all subjects and with breast cancer in female subjects. Subjects with a metabolically unhealthy normal weight had a higher risk of pancreatic cancer. Moreover, MUHO was associated with corpus uteri cancer in female subjects. This prospective cohort study suggests that metabolic phenotypes are important risk factors for total and some site-specific cancers in Japanese adults. Significance: The prospective cohort study in a large Japanese population suggested that metabolic phenotypes are important risk factors for total and some site-specific cancers in Japanese adults. Moreover, the risk of each site-specific cancer may differ according to metabolic phenotypes.
Year:
2024
Year:
2023
Year:
2023
Year:
2023
Collaborators (19)
Teruhide Koyama
Kyoto Prefectural University of Medicine
TAKUMA FURUKAWA
Assistant Professor
Saga University
Megumi Hara
Associate professor
Saga Daigaku
Ryosuke Fujii
Senior Assistant Professor
Fujita Health University
Chisato Shimanoe
Director/ Professor
Saga University
Masashi Ishizu-Jo
Assistant Professor
Tokushima University
Kazuhiko Watanabe
Assistant professor
University of Occupational and Environmental Health Japan
Koji Suzuki
Professor
Fujita Health University
Hiroaki Ikezaki
Associate Professor
Kyushu University Graduate School of Medical Sciences
Isao Oze
Unit Leader
Aichi Cancer Center
Keitaro Tanaka
Saga University
Yuriko N Koyanagi
Aichi Cancer Center
Shuntaro Sato
Nagasaki University
Takeshi Watanabe
Assistant Professor
Tokushima University
Naoyuki Takashima
Professor
Kyoto Prefectural University of Medicine
Keitaro Matsuo
Chief
Nagoya University
Sadao Suzuki
Professor
Nagoya Daigaku
Nobuaki Michihata
The Univeristy of Tokyo
Hidemi Ito
Division Chief
Aichi Cancer Center
Make your next move.
Prepare your application
Review drafts before you send them.